2019
DOI: 10.1111/avj.12875
|View full text |Cite
|
Sign up to set email alerts
|

Primary immune‐mediated haemolytic anaemia: a retrospective long‐term study in 61 dogs

Abstract: Objectives The objective of this study is to describe the course of disease of dogs with primary immune-mediated haemolytic anaemia (pIMHA) with an observation period longer than 90 days in regard to clinical signs, laboratory results and treatment response.Material and methods Clinical records between January 2003 and December 2011 were reviewed. Diagnosis of pIMHA was based on the presence of haemolytic anaemia with a packed cell volume of <0.35 L/L, a positive Coombs' test and/or erythrocyte agglutination, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
9
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 35 publications
1
9
0
3
Order By: Relevance
“…Hemolysis can occur in a variety of pathological or disease conditions such as autoimmune hemolytic anemia, sickle cell anemia, thalassemia, glucose-6-phosphate dehydrogenase deficiency, exposure to certain chemicals, medicine, and toxins, blood clots, transfusion, and infection (Francis et al, 2013). Integrin α4β1/VCAM-1 interaction in hemolysis could evoke the immune response leading to corresponding cell dysfunction as shown in the present data and reported by others (Weingart et al, 2019;Dickmann and Bauer, 2020;Imataki et al, 2020;Yang et al, 2020). Therefore, exploration of innovative approaches to the therapy of immune disorders caused by hemolysis is highly demanded.…”
Section: Discussionsupporting
confidence: 79%
“…Hemolysis can occur in a variety of pathological or disease conditions such as autoimmune hemolytic anemia, sickle cell anemia, thalassemia, glucose-6-phosphate dehydrogenase deficiency, exposure to certain chemicals, medicine, and toxins, blood clots, transfusion, and infection (Francis et al, 2013). Integrin α4β1/VCAM-1 interaction in hemolysis could evoke the immune response leading to corresponding cell dysfunction as shown in the present data and reported by others (Weingart et al, 2019;Dickmann and Bauer, 2020;Imataki et al, 2020;Yang et al, 2020). Therefore, exploration of innovative approaches to the therapy of immune disorders caused by hemolysis is highly demanded.…”
Section: Discussionsupporting
confidence: 79%
“…O tratamento da AHIM consiste em cuidados de suporte e terapia com imunossupressores com corticosteroides, a fim de que haja depressão do sistema imune e não haja resposta contra os eritrócitos [6]. Inicialmente, foi suspendido o cloridrato de tramadol, dipirona e amoxicilina com clavulanato de potássio, com intuito de interromper a causa da AHIM, e foi iniciada a administração de dexametasona em dose imunossupressora.…”
Section: Discussionunclassified
“…Inicialmente, foi suspendido o cloridrato de tramadol, dipirona e amoxicilina com clavulanato de potássio, com intuito de interromper a causa da AHIM, e foi iniciada a administração de dexametasona em dose imunossupressora. Posteriormente, o animal começou a apresentar efeitos adversos, como poliúria, polidipsia, taquipneia e diarreia, bem como descrito na literatura como sinais colaterais a terapia com dexametasona [5,6].…”
Section: Discussionunclassified
See 1 more Smart Citation
“…
Immune-mediated hemolytic anemia (IMHA) characterized by activation of the complement system and production of autoantibodies resulting in erythrocyte destruction is one of the most common hematological problems among dogs (7,23). IMHA diagnosis is a rule-out diagnosis.
…”
mentioning
confidence: 99%